Automated Insulin Delivery Systems
AHCL Systems: a technological innovation for Diabetes Management
Advanced Hybrid Closed-Loop (AHCL) systems represent the latest technological advance in the treatment of type 1 diabetes and consist of three components: a control algorithm, an insulin pump and Continuous Glucose Monitoring (CGM). AHCL systems are capable of automatically delivering insulin, adjusting to rising and falling requirements, and delivering automatic correction boluses as needed, based on glucose predictions derived from continuous glucose monitoring (CGM). Treatment with AHCL systems improves glycaemic variability, reduces the frequency of hypoglycaemia and significantly increases the time spent within the target range. Furthermore, it helps to reduce the burden of daily diabetes management, thereby improving quality of life.
System’s components
1
Tandem t: slim X2 pump with Control-IQ+ technology
2
Dexcom G7 and FSL3+ continuous glucose monitoring systems
3
Predictive control algorithm
System's main features
Predictive Technology
The algorithm predicts blood glucose levels over the next 30 minutes, automatically adjusts insulin delivery and, where necessary, delivers automatic correction boluses
Active immediately and always on
To promote Time In Range improvement
Easy to start
By entering 3 parameters only, the algorithm starts immediately, with immediate improvement in Time In Range1
Easy to use
It simplifies daily diabetes management and improves users’ quality of life2, while also simplifying clinician management
Software upgraded remotely
Access to future features without having to replace components or physically travel to a clinic
Tandem t:slim X2 with Control-IQ+ technology
- A 30-minute predictive algorithm that automatically adjusts insulin delivery based on predicted blood glucose trends and provides correction boluses as needed;
- Ability to set temporary basal profiles and extended boluses lasting up to eight hours, even while the algorithm is automatically adjusting insulin delivery;
- Accessible to children aged 2 and to patients with very low or very high insulin requirements;
- “Sleep Activity” and “Exercise Activity” functions to better manage night rest and physical activity;
- Compact, lightweight, and waterproof;
- Large color touchscreen, intuitive and easy to use;
- Rechargeable battery via micro-USB port.
Dexcom G7 and FreeStyle Libre 3 Plus
Tandem t:slim X2 insulin pump with Control-IQ+ technology integrates Dexcom G7 and FreeStyle Libre 3 Plus Continuous Glucose Monitoring (CGM) systems, offering flexibility of choice for various clinical and lifestyle needs.
- Dexcom G7 is a compact, all-in-one CGM system with a short warm up period, maximizing time spent in closed-loop mode³;
- FreeStyle Libre 3 Plus is a next-generation CGM system designed to provide accurate and discreet continuous monitoring.
Tandem t:slim Mobile App
An app that makes managing diabetes easier: using your smartphone, you can deliver or cancel boluses, view pump data, and receive push notifications with complete discretion. In addition, treatment data is automatically uploaded wirelessly to the Tandem Source platform, eliminating the need to download data at the clinic. Diabetes management thus becomes less intrusive, reducing mental burden and improving adherence to treatment.
Infusion sets
Choosing the right infusion set is crucial to the success of pump therapy. We offer different types of cannula, catheter lengths, angles, and insertion methods to meet all clinical and personal needs of every Tandem t:slim X2 user.
AutoSoft™ 90 Infusion Set
AutoSoft™ 30 Infusion Set
VariSoft™ Infusion Set
TruSteel™ Infusion Set
Need more information?
All content material on this website is intended for informational purposes only and is in no way a replacement for medical advice.